1 |
Bakry et al. [11] |
In vitro investigation |
|
2 |
Burwell et al. [12] |
In vitro investigation |
|
3 |
Burwell et al. [13] |
In vitro investigation |
|
4 |
Chiang et al. [14] |
In vitro investigation |
|
5 |
Earl et al. [15] |
In vitro investigation |
|
6 |
Farmakis et al. [16] |
In vitro investigation |
|
7 |
Gillam et al. [17] |
In vitro investigation |
|
8 |
Gjorgievska and Nicholson [18] |
In vitro investigation |
|
9 |
Golpayegani et al. [19] |
In vitro investigation |
|
10 |
Mitchell et al. [20] |
In vitro investigation |
|
11 |
Mneimne et al. [21] |
In vitro investigation |
|
12 |
Parkinson et al. [22] |
Abstract only (at the time of collection of papers). However as the study lacked a negative control in the clinical trial design methodology it was excluded from the present review |
|
13 |
Sauro et al. [23] |
In vitro investigation |
|
14 |
Wang et al. [24] |
In vitro investigation |
|
15 |
Wang et al. [25] |
In vitro investigation |
|
16 |
Greenspan [26] |
Review |
|
17 |
Du et al. [27] |
No mention of randomisation and allocation concealment methods |
|
18 |
Patsouri et al. [28] |
Abstract only |
|
19 |
Surve et al. [29] |
Abstract only (at the time of collection of papers). However the study investigated the combination of an In-office application with or without a OTC desensitizing toothpaste following periodontal treatment and was therefore considered irrelevant for the present review |
|
20 |
Yu et al. [30] |
Publication in Chinese (Abstract in English) |
|
21 |
Milleman et al. [31] |
In-office agent (professionally applied polishing paste) and not as an OTC desensitizing toothpaste |
|
22 |
Narongdej et al. [32] |
Novamin used as in-office agent |
|
23 |
Banerjee et al. [33] |
Study duration ≤10 days |
|
24 |
Tai et al. [37] |
Investigated the antigingivitis effect of Novamin on the gingival tissues (desensitizing toothpaste per se) and therefore the study was considered irrelevant to this review |
|
25 |
Acharya et al. [34] |
Excluded as the publication date was after December 31st and lacked a negative control in the clinical trial design methodology |
|
26 |
Ananthakrishna et al. [35] |
Excluded as the publication date was after December 31st and lacked a negative control in the clinical trial design methodology |
|
27 |
Neuhaus et al. [36] |
Excluded as the publication date was after December 31st and evaluated an In-office agent (professionally applied polishing paste) |
|
28 |
Salian et al. [38] |
The negative control group contained fluoride whereas the test group (Novamin) did not |
|
29 |
Sharma et al. [39] |
The negative control group contained fluoride whereas the test group (Novamin) did not |
|
30 |
West et al. [40] |
The dentine specimens were placed in intraoral appliances worn by patients to establish an in situ effect of Novamin |
|
31 |
Rajesh et al. [41] |
One further study was excluded due to the lack of description on the composition of the control randomization |